Segments Covered in this Procedure Volume Research
This market study focuses specifically on the volume of procedures. It includes analysis of procedures.
This data outlines the exact growth rates for procedures. If you’re interested in seeing the trends in procedures to formulate your market sizing and forecasts this is the most accurate and most affordable way to do it.
About Procedure Volume Research (MedPro) Our analysts meticulously research for 3 to 4 months to put together a suite of reports, which is a comprehensive analysis on a group of healthcare markets. A MedPro is one portion of that analysis that outlines only the procedure volumes and forecasts for each market in that suite of reports.
This procedural analysis is incorporated in our market size analysis and forecasting which are available when purchasing a MedSuite, MedView or MedCore.
Where Do We Get Our Procedure Data? Our team of analysts has proprietary data that we’ve been collecting for over a decade as well as government and private databases like that from CMS and hospital records. By looking at multiple sources we are able to triangulate on orthopedic soft tissue procedure volumes that influence and coincide with our overall market sizing.
Questions This Report will Help You Answer: What is affecting the volume of procedures?
How many procedures were done in 2016?
How many procedures were done historically?
How many procedures can we expect in 2023 and what is the growth trend?
Abstract The full report suite on the European market for vascular access devices and accessories includes implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs), dialysis catheters, manufactured catheter securement devices (MCSDs) and syringes and needles. Vascular access devices are used for gaining access to a patient’s bloodstream via the veins.
They can deliver a wide range of treatments, including fluid infusion, blood draws, parenteral nutrition, antibiotics, chemotherapy and dialysis. The duration of treatment lasts anywhere from hours to years, depending on the type of vascular access device used and the type of medication that is being infused.
Our reports have been used by over 10K customers, including:
The major factors for the growth of the novel drug delivery systems (NDDS) market include the growing need of controlled release of drugs, advancement in pharmacology promoting increased adoption of novel drug delivery systems (NDDS), and technological advancements promoting the development of NDDS. There has been a remarkable increase...
Report Scope: The scope of the report includes an overview of the global market for nanoparticles in biotechnology, drug development and drug delivery, and analyses of global market trends, using 2019 as the base year and forecasting 2020 through 2025 with compound annual growth rate (CAGR) projections. The report...
The Europe liposome drug delivery market was valued at US$ 1,164.54 million in 2019 and is projected to reach US$ 2,160.12 million by 2027; it is expected to grow at a CAGR of 8.2% during the forecast period. The growing R&D expenditure on drug delivery, growing demand for non-invasive drug delivery devices. and the development of new...
The Europe wearable injectors market is expected to reach US$ 3586.82 million in 2027 from US$ 1539.88 million in 2019. The market is estimated to grow with a CAGR of 11.3 % from 2020 to 2027. The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development,...
INTRODUCTION Over the years, advances in cell biology and pharmacology have led to the development of a variety of advanced biologics, which experts believe, possess the potential to address several unmet needs associated with the treatment of different types of diseases. Currently, there are more than 1,000 cell and gene...
Summary Milestone Scientific Inc (Milestone Scientific) is a medical device company that designs, manufactures and distributes computer controlled drug delivery instruments in the medical and dental fields.The company’s medical specialties include anesthesiology, pain medicine, orthopedic surgery, physical medicine and...
510 pages •
By Roots Analysis Private Ltd.
• May 2020
Chronic diseases, such as diabetes, cardiovascular disorders, neurological disorders, autoimmune disorders and various types of cancer, are known to be the leading causes of death and disability across the world. The clinical conditions associated with these diseases affect patients’ overall quality of life....
The liposome drug delivery market is expected to reach US$ 6,992.95 million by 2027 from US$ 3,594.41 million in 2019. The market is estimated to grow at a CAGR of 8.8% from 2020 to 2027.
The growth of the market is attributed to a few key driving factors such as increasing prevalence of chronic diseases, growing demand for noninvasive...
Drug Delivery Devices Market by Device Type (Smart Pills, Inhalers & Nebulizers, Drug Eluting Stents, Safety Syringes, Implantable Drug Delivery Device, and Transdermal Patches, and, Others), End User (Hospitals and Diagnostic Centers, Ambulatory Surgery Centers and Clinics and Others), Global Opportunity Analysis and Industry Forecast,...
Chronic Disease Prevalence
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.